Table 1 Clinical and biological data of the 134 patients with mild to moderate CKD
Age (years) | 46.5 (30.5–59.0) |
Sex (male, n = ) | 84 (62.6%) |
Ethnicity | Caucasian/white: n = 89; Afro-American: n = 23; Asian/Asian American: n = 15; Multi-racial: n = 4; |
Diagnosis | MN: n = 43; MCD n = 27; FSGS: n = 36; IgAN n = 17; other: n = 11 |
HTN at biopsy (n = ) | 71 (53.0%) |
eGFR at biopsy (mL/min/1.73 m2) | 84.0 (65.0–104.9) |
UPCR at biopsy (g/g) | 3.8 (1.5–6.7) |
Follow-up (months) | 47.0 (30.3–55) |
ESRD or decrease of 40% eGFR (n = ) | 31 (23%) |
eGFR slope (mL/min/1.73 m2) | −1.62 (−4.6–1.1) |
Fast progressors (n = ) | 36 (26.9%) |